SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alexander McGirr, David J. Bond, Comprehensive Pharmacologic Management of Bipolar Depression, Current Treatment Options in Psychiatry, 2014, 1, 3, 263

    CrossRef

  2. 2
    Maria Francesca Moro, Mauro Giovanni Carta, Evaluating aripiprazole as a potential bipolar disorder therapy for adults, Expert Opinion on Investigational Drugs, 2014, 23, 12, 1713

    CrossRef

  3. 3
    Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Roumen Milev, David J Bond, Benicio N Frey, Benjamin I Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A Nolen, Michael Berk, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disorders, 2013, 15, 1
  4. 4
    Hideaki Katagiri, Mauricio Tohen, David P McDonnell, Shinji Fujikoshi, Michael Case, Shigenobu Kanba, Michihiro Takahashi, Juan-Carlos Gomez, Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study, BMC Psychiatry, 2013, 13, 1, 138

    CrossRef

  5. 5
    M. Tohen, H. Katagiri, S. Fujikoshi, S. Kanba, Efficacy of olanzapine monotherapy in acute bipolar depression: A pooled analysis of controlled studies, Journal of Affective Disorders, 2013, 149, 1-3, 196

    CrossRef

  6. 6
    Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller, Eduard Vieta, Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry, European Archives of Psychiatry and Clinical Neuroscience, 2012, 262, S1, 1

    CrossRef

  7. 7
    M. Tohen, D. P. McDonnell, M. Case, S. Kanba, K. Ha, Y. R. Fang, H. Katagiri, J.-C. Gomez, Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression, The British Journal of Psychiatry, 2012, 201, 5, 376

    CrossRef

  8. 8
    Lakshmi N. Yatham, A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder, Journal of Affective Disorders, 2011, 128, S21

    CrossRef

  9. 9
    P.-M. Llorca, Antipsychotiques de seconde génération dans la dépression bipolaire : une nouvelle option thérapeutique ?, L'Encéphale, 2011, 37, S209

    CrossRef

  10. 10
    Andrea Fagiolini, Maria Nitti, Rocco N Forgione, Francesco S Marra, Francesco Casamassima, Aripiprazole for the treatment of bipolar disorder: a review of current evidence, Expert Opinion on Pharmacotherapy, 2011, 12, 3, 473

    CrossRef

  11. 11
    Martin A. Katzman, Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness, Journal of Affective Disorders, 2011, 128, S11

    CrossRef

  12. 12
    Rif S. El-Mallakh, Ahmed Z. Elmaadawi, Muruga Loganathan, Kavita Lohano, Yonglin Gao, Bipolar Disorder: An Update, Postgraduate Medicine, 2010, 122, 4, 24

    CrossRef

  13. 13
    Andrea Cipriani, Marianna Purgato, Toshi A Furukawa, Carlotta Trespidi, Giuseppe Imperadore, Alessandra Signoretti, Rachel Churchill, Norio Watanabe, Corrado Barbui, Citalopram versus other anti-depressive agents for depression, The Cochrane Library,